Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial

NCT01160926 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
31
Enrollment
OTHER
Sponsor class

Stopped 2 DLTs had been reported from first 4 patients on lowest possible dose cohort.

Conditions

Interventions

Sponsor

The Christie NHS Foundation Trust

Collaborators